Moreover, deconvolution of these populations in transcriptomic datasets revealed that enrichment for the TRM gene signature was associated with improved overall survival in BC patients, whereas TEX gene signature enrichment correlated with poorer outcomes (Fig. 2l). Here, TEX46 is linked to breast cancer.